77592675 - LIFE TECHNOLOGIES

Information

• Trademark
• 77592675

• Source

• Serial Number

  77592675

• Registration Number

  4422138

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 16 - Paper, cardboard and goods made from these materials, not included in other classes
  • 37 - Building construction
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  October 14, 2008
  16 years ago

• Registration Date

  October 22, 2013
  11 years ago

• Transaction Date

  July 03, 2024
  8 months ago

• Status Date

  March 22, 2024
  11 months ago

• Published for Opposition Date

  November 02, 2010
  14 years ago

• Renewal Date

  October 22, 2023
  a year ago

• Location Date

  March 22, 2024
  11 months ago

• First Use Anywhere Date

  October 01, 2012
  12 years ago

• First Use In Commerce Date

  October 01, 2012
  12 years ago

• Status Code

  800

• Current Location

  GENERIC WEB UPDATE

  Employee Name

  ESTRADA, LINDA M

• Attorney Name

  Kenya L. Williams

  Law Office Assigned Location Code

  L40

• Owners

  • Life Technologies, Inc.
  • Invitrogen Corporation

Case File Statements

• GS0091: Computer software used for the collection, organization, analysis, integration and communication of scientific data; computer software used to operate laboratory instruments; laboratory instruments, namely, nucleic acid sequencers and synthesizers, genetic analyzers, [ thermal cyclers, cytometers, protein and peptide synthesizers, mass spectrometers and chromatographs, laboratory instruments for preparation of nucleic acid samples, laboratory robots; laboratory supplies, namely, racks, vials, caps, septa, needles, bottles, flasks, ] [ filters, ] [ tubes, and seals, plastic tray covers, micro plates, pipette tips, reagent reservoirs, optical heat field covers, plastic cards, and plastic capillary arrays; all ] for scientific and research use and diagnostics use [ ; computer software for the construction of recombinant DNA molecules in the fields of molecular biology and genetics, building of functional or restriction maps, describing recombinant molecules, and obtaining the exact nucleotide sequences of recombinant DNA molecules; and computer software for use in database management in the fields of molecular biology and genetics that may be downloaded from a global computer network and computer software for use in database management in the fields of molecular biology and genetics; magnetic particle concentrator to be used with magnetic particle-based biomedical separations; full line of laboratory apparatus for protein and nucleic acid electrophoresis; ] [ optical filters for wavelengths of light; ] [ detectors using light sources for identifying proteins, nucleic acids, cellular metabolites, carbohydrates, viruses, bacteria and/or eukaryotic cells; analyzers for laboratory uses for identifying proteins, nucleic acids, cellular metabolites, carbohydrates, viruses, bacteria and/or eukaryotic cells; laboratory instruments for performing automated washing, dispensing, hybridization, and imaging of chip based sequence specific oligonucleotides; fluorometer or spectrophotometer used for detection and quantitation of DNA, RNA, protein or other analytes in solution, detachable power cord; ] [ detachable Universal Serial Bus (USB) data cord; scientific apparatus, namely, assay tubes; ] [ software for analysis or results, all for use with a fluorometer or spectrophotometer; laboratory instrument for the detection of pathogens and/or toxins in a sample; laboratory equipment, namely, apparatus in the nature of biochips for identification, detection of presence of biological or chemicals in a sample and determination of physical or chemical properties of a sample, synthesizers for making polymer arrays and parts therefor, and hybridization stations for making fluidic and microfluidic devices ]
• A00001: In the statement, page 2, line 80, "filters" is deleted.
• GS0161: [ Newsletters on products for scientific research ]
• GS0051: Microbiological culture media, animal blood sera, mammalian and insect cells, mammalian and insect cell culture media and cell culture reagents, all for medical diagnostic use [ ; diagnostic biochemical and biological reagents for medical purposes in the detection or treatment of illnesses; chemical reagents for medical uses in the detection of pathogens and/or toxins in veterinary samples; ] [ pharmaceuticals preparations and compositions for therapeutic use, namely, for expanding, selecting and deleting cells of the immune systems; ] [ preparations and compositions for therapeutic use, namely, for activating cells of the immune systems; ] [ pharmaceutical preparations for use in the treatment of cancer, infectious diseases and immunodeficiencies; ] [ antibody-conjugated beads, antibody-conjugated micro-beads and antibody-conjugated microspheres for promoting a therapeutic effect on the body ]
• GS0371: [ Installation, maintenance and repair of laboratory instruments for scientific, research, medical, and diagnostics use; Installation, maintenance and repair of computer hardware for scientific, research, medical, and diagnostics use ]
• GS0011: Reagents and kits comprised of reagents for scientific or medical research use; diagnostic reagents and kits comprised of diagnostic reagents for scientific or medical research use; [ cellular pathway exploration tools, namely, enzyme-linked immunosorbent assay (ELISA), kinase activity assays, protein arrays, recombinant proteins and antibodies all for analysis of multiple proteins and pathways in the field of scientific research; human, mouse and rat markers and antibodies conjugated to fluorescent chemical dyes, and human, mouse and rat markers and antibodies conjugated to proteins, namely, cytokines and chemokines, all for use in flow cytometry; ] culture media for non-medical use, culture growth supplements in the nature of biochemicals, reagents for use in cultures; all for use in scientific, laboratory, and medical research; [ in vitro ADME cell products, namely, fresh and cryopreserved hepatocytes and liver subcellular fractions, and transporters derived from a variety of species, including human, non-human primate, dog, rat and mouse for scientific research; magnetic particle-based biomedical separation systems comprising magnetizable polymer beads, the attached antibody and the magnetic particle concentrator for separating a specific selected cell population from a larger, more complex cell population for scientific research; biological and biochemical preparations, namely, reagents and kits consisting of proteins, PCR fragments, cDNA libraries, vectors, enzymes, molecules, clones, genes, cell, recombination proteins and sites, restriction enzymes, primers, plasmids, and reagents all for scientific medical research, or research use. ] Microbiological culture media, animal blood sera, mammalian and insect cells, mammalian and insect cell culture media and cell culture reagents, all for scientific or medical research use [ ; full line of kits consisting primarily of one or more of the following, namely, protein arrays, nucleic acids, hormones, purification supports, resins, cells, gels, probes, buffers, stains and associated reagents and devices for the expression, amplification, purification and analysis of biological samples; fluorescent chemicals for use in scientific research; electrophoresis gel and chromatography chemicals, buffers, and solutions for scientific research; research and diagnostic biochemical and biological reagents, other than for medial or veterinary purposes, for agricultural, ecological, DNA typing, food processing and research laboratories; reagents and assays used for detection and quantitation of DNA, RNA, protein or other analytes in solution, sold individually or in kits for research use; chemical reagents for non-medical purposes for the detection of pathogens and/or toxins in environmental samples; synthetic DNA for use in biotechnology; synthetic DNA and molecules used as DNA molecular weight standards for use in the biotechnology field; nucleotide arrays for scientific research; biochemical reagents for scientific research; buffers for use in analytical chemistry all for scientific and medical research use; chemicals used for medical purposes, namely, reagents containing ligands, effector molecules and antibodies all for scientific or medical research use; antibody-conjugated micro-beads and antibody-conjugated microspheres all for scientific and medical research use and for activation of immune system cells; cell culture reagents for medical laboratory use; fluorescent chemical dyes for clinical medical laboratory use, namely, for measurement of pH in medical laboratories ]
• GS0441: [ Consultation in the field of medicine, health and pharmaceuticals ]
• DS0000: "TECHNOLOGIES"
• GS0421: [ Providing an on-line computer database featuring information in the field of scientific and medical research; research in the fields of science, technology, medicine and health, namely, nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; consultation services in the field of science and technology consultation in the field of nucleic acid sequencing, analysis and synthesis of igonucleotides and other molecules for others for use in life science research and biotechnology research; computer services, namely, providing temporary use of on-line non-downloadable software for accessing and analyzing information in the field of science, technology, medicine, health and public policy; medical, research and laboratory diagnostic services in the field of nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; product development for others; laboratory services, namely, nucleic acid sequencing, synthesis and analysis, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; installation, maintenance and repair of computer software for scientific, research, medical, and diagnostic use; nucleic acid analysis; genetic research, namely, gene discovery; genetic disease research, genomics and gene expression research and development; pharmacokinetic research services; proteomics research services; gene identification, gene cloning, gene expression, gene mapping, electrophoresis, protein purification and analysis, and protein interaction detection all for scientific purposes; medical and scientific research; medical and scientific research for the development and commercialization of cell-based therapeutic immune system stimulators and enhancers to treat cancer and infectious diseases; technical research and consultation related thereto in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices; development of new products in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices for others; medical laboratory services; research and development for new immunotherapy products for others; biopharmaceutical research and development; scientific research services; medical laboratory testing and diagnostic services for others in the fields of science and research related thereto; scientific research, namely, developing customized microbiological, mammalian, and insect culture media, media formulations, and cell culture reagents, and evaluating culture media for others; contract laboratory services, namely, conducting drug-drug interaction studies, drug metabolism studies and hepatotoxicity studies, namely, enzyme induction and inhibition, reaction phenotyping, metabolite stability and profiling, and P-gp assays, and consulting services related thereto ]

Case File Event Statements

• 1/21/2009 - 16 years ago

  3 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/17/2008 - 16 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 1/13/2009 - 16 years ago

  2 - ASSIGNED TO EXAMINER Type: DOCK

• 1/21/2009 - 16 years ago

  4 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/21/2009 - 16 years ago

  5 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 6/24/2009 - 15 years ago

  6 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/24/2009 - 15 years ago

  7 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/25/2009 - 15 years ago

  8 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/16/2009 - 15 years ago

  9 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/16/2009 - 15 years ago

  10 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/16/2009 - 15 years ago

  11 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 1/14/2010 - 15 years ago

  12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/25/2010 - 15 years ago

  13 - ASSIGNED TO LIE Type: ALIE

• 2/19/2010 - 15 years ago

  14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/19/2010 - 15 years ago

  15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/15/2010 - 14 years ago

  16 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/15/2010 - 14 years ago

  17 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/15/2010 - 14 years ago

  18 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/2/2010 - 14 years ago

  19 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/2/2010 - 14 years ago

  20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/3/2010 - 14 years ago

  21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/23/2010 - 14 years ago

  22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/25/2010 - 14 years ago

  23 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 11/2/2010 - 14 years ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/2/2010 - 14 years ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/3/2010 - 14 years ago

  26 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK

• 12/2/2010 - 14 years ago

  27 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 2/1/2011 - 14 years ago

  28 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 3/18/2011 - 13 years ago

  29 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP

• 5/3/2011 - 13 years ago

  30 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 8/2/2011 - 13 years ago

  31 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 8/2/2011 - 13 years ago

  32 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 10/25/2011 - 13 years ago

  33 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 10/25/2011 - 13 years ago

  35 - SOU EXTENSION 1 FILED Type: EXT1

• 10/26/2011 - 13 years ago

  34 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 10/27/2011 - 13 years ago

  36 - SOU EXTENSION 1 GRANTED Type: EX1G

• 10/28/2011 - 13 years ago

  37 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 5/1/2012 - 12 years ago

  38 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 5/1/2012 - 12 years ago

  39 - SOU EXTENSION 2 FILED Type: EXT2

• 5/9/2012 - 12 years ago

  40 - SOU EXTENSION 2 GRANTED Type: EX2G

• 5/10/2012 - 12 years ago

  41 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 10/23/2012 - 12 years ago

  42 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 10/23/2012 - 12 years ago

  43 - SOU EXTENSION 3 FILED Type: EXT3

• 5/1/2013 - 11 years ago

  47 - SOU EXTENSION 4 FILED Type: EXT4

• 10/25/2012 - 12 years ago

  44 - SOU EXTENSION 3 GRANTED Type: EX3G

• 10/26/2012 - 12 years ago

  45 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 5/1/2013 - 11 years ago

  46 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 5/24/2013 - 11 years ago

  48 - SOU EXTENSION 4 GRANTED Type: EX4G

• 5/25/2013 - 11 years ago

  49 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 8/12/2013 - 11 years ago

  50 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 8/12/2013 - 11 years ago

  51 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 8/12/2013 - 11 years ago

  52 - SOU EXTENSION 5 FILED Type: EXT5

• 8/12/2013 - 11 years ago

  54 - USE AMENDMENT FILED Type: IUAF

• 8/13/2013 - 11 years ago

  53 - SOU EXTENSION 5 GRANTED Type: EX5G

• 8/13/2013 - 11 years ago

  55 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 8/14/2013 - 11 years ago

  56 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 9/5/2013 - 11 years ago

  57 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 9/13/2013 - 11 years ago

  58 - LAW OFFICE REGISTRATION REVIEW COMPLETED Type: REGV

• 9/14/2013 - 11 years ago

  59 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 10/22/2013 - 11 years ago

  60 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 7/23/2014 - 10 years ago

  61 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 7/23/2014 - 10 years ago

  62 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 10/22/2018 - 6 years ago

  63 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 10/18/2019 - 5 years ago

  64 - TEAS SECTION 8 & 15 RECEIVED Type: E815

• 11/23/2019 - 5 years ago

  65 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 11/23/2019 - 5 years ago

  66 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P

• 11/23/2019 - 5 years ago

  67 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85

• 4/16/2021 - 3 years ago

  68 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R

• 4/22/2021 - 3 years ago

  69 - AMENDMENT UNDER SECTION 7 - PROCESSED Type: A7OK

• 10/22/2022 - 2 years ago

  70 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2

• 3/10/2023 - 2 years ago

  71 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 3/10/2023 - 2 years ago

  72 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 3/10/2023 - 2 years ago

  73 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 3/10/2023 - 2 years ago

  74 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 3/10/2023 - 2 years ago

  75 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 10/23/2023 - a year ago

  76 - TEAS SECTION 8 & 9 RECEIVED Type: E89R

• 3/22/2024 - 11 months ago

  77 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 3/22/2024 - 11 months ago

  78 - REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Type: 89AG

• 3/22/2024 - 11 months ago

  79 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Type: RNL1

• 3/22/2024 - 11 months ago

  80 - NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Type: NA89